GMEB-2 Antibodies

Santa Cruz Biotechnology offers a broad range of GMEB-2 monoclonal antibodies to support research needs. GMEB-2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GMEB-2, or G2/M phase-specific E3 ubiquitin ligase, plays a critical role in cell cycle regulation and is involved in the degradation of specific proteins that control cell division. Its proper function is essential for maintaining cellular homeostasis and preventing uncontrolled cell proliferation, which can lead to cancer. Understanding GMEB-2's mechanisms can provide insights into various diseases and potential therapeutic targets. GMEB-2 monoclonal antibodies enable researchers to explore cell cycle regulation pathways and their impact on cellular processes. Investigating GMEB-2's role in protein degradation can reveal new perspectives on cell division control mechanisms. Research utilizing GMEB-2 monoclonal antibodies may uncover novel therapeutic approaches for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by facilitating research in cell cycle regulation and disease mechanisms.